The Centers for Medicare and Medicaid Services has released revised guidance on how it intends to use its authority with pharmaceutical manufacturers in the Medicare Drug Negotiation Program.
The Department of Health and Human Services has issued a final rule that amends civil money penalties for information blocking related to HHS grants, contracts and other agreements.
UnitedHealthcare has adopted a $0 out-of-pocket expense benefit for virtual visits for eligible members enrolled in applicable fully insured employer-sponsored plans.
The new coverage enhancement is designed to make remote urgent care more affordable a…
The Center for Medicare and Medicaid Innovation has released a new, voluntary Enhancing Oncology Model (EOM) intended to reduce spending and improve quality of care for cancer patients.
The EOM is a 5-year voluntary model, beginning on July 1, that ha…
NASHVILLE – An estimated three-quarters of physicians are employed by hospitals, according to information released at the HFMA session “Closing the Financial Data Gap in a Physician Alignment Strategy.”
CMS is proposing to increase the end stage renal disease prospective payment base rate to $269.99 for 2024, increasing total payments to freestanding ESRD facilities by $4.42, or approximately 1.6%, compared to 2023.
For hospital-based ESRD facilities,…
NASHVILLE – Revenue cycle vendor management has saved two health systems millions, according to two vice presidents of revenue cycle speaking at HMFA 2023.
Total savings for the Vanderbilt University Medical Center has been $1.9 million to date, accord…
Optum is acquiring home health, hospice and acuity care provider Amedisys in an all-cash deal valued at an estimated $3.3 billion.
The agreement calls for the acquisition of Amedisys’s outstanding common stock in an all-cash transaction for $101 per sh…
NASHVILLE – Four health system CFOs on Sunday kicked off the opening keynote session of the Healthcare Financial Management Association annual conference by summing up the challenges hospitals have overcome and how they’re tackling those ahead.
The Centers for Medicare and Medicaid Services is releasing new details about how people can get drugs that may slow the progression of Alzheimer’s disease covered by Medicare.
If the Food and Drug Administration grants traditional approval, then Medic…